Skip to main content
DONGWHA PHARM.CO.,LTD logo

DONGWHA PHARM.CO.,LTD — Investor Relations & Filings

Ticker · 000020 ISIN · KR7000020008 KO Manufacturing
Open in API
Filings indexed 223 across all filing types
Latest filing 2023-11-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 000020

About DONGWHA PHARM.CO.,LTD

https://www.dong-wha.co.kr

Dongwha Pharm is a pharmaceutical company engaged in the research, development, manufacturing, and sale of a diverse range of healthcare products. Its portfolio includes ethical (prescription) pharmaceuticals, over-the-counter (OTC) drugs, medical devices, quasi-drugs, health functional foods, cosmetics, and beverages. The company's research and development efforts focus on various therapeutic areas, including alimentary and cardiovascular systems. Dongwha Pharm actively pursues innovation through its drug pipeline, clinical trials, and strategic investments in emerging fields like digital therapeutics.

Recent filings

Filing Released Lang Actions
분기보고서 (2023.09)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (분기보고서) for Dong-A Pharmaceutical Co., Ltd. covering the period from January 1, 2023, to September 30, 2023. It contains detailed financial statements, business operations, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2023
2023-11-14 Korean
자기주식처분결과보고서
Transaction in Own Shares Classification · 1% confidence The document is a 'Report on the Results of Disposal of Treasury Shares' (자기주식처분결과보고서) filed by Dongwha Pharm. It details the specific number of shares disposed of, the date of disposal, and the purpose (employee stock ownership association contribution). This falls under the category of a company reporting the disposal or transaction of its own shares, which corresponds to the 'Transaction in Own Shares' (POS) category.
2023-11-02 Korean
[기재정정]타법인주식및출자증권취득결정
M&A Activity Classification · 1% confidence The document is a regulatory filing from Dongwha Pharm regarding the acquisition of shares in another company (TSCARE JOINT STOCK COMPANY). It is a 'Correction Report' (정정신고) detailing changes to the expected acquisition date. This type of corporate action, specifically related to mergers and acquisitions or strategic investments, falls under the M&A Activity category.
2023-10-31 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean Financial Supervisory Service/Korea Exchange regarding a 'Decision to Dispose of Treasury Shares' (자기주식 처분 결정). This document details the company's plan to dispose of its own shares (treasury stock) for the purpose of an employee stock ownership association contribution. Since the document specifically reports the company's action of disposing of its own shares, it falls under the category of 'Transaction in Own Shares' (POS).
2023-10-27 Korean
공정거래자율준수프로그램운영현황(안내공시)
Governance Information Classification · 1% confidence The document is a regulatory disclosure from Dongwha Pharm regarding its 'Compliance Program (CP)' operational status, including past performance and future plans. It is filed as an 'Information Disclosure' (안내공시) to the public/regulators. Since it does not fit into specific categories like financial reports, M&A, or shareholder voting, and serves as a general regulatory update on corporate governance/compliance practices, it is best classified as a Regulatory Filing (RNS).
2023-10-27 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document details the shareholding status of major shareholders and their special relations, including changes in share ownership and collateral agreements. This falls under the category of 'Major Shareholding Notification' (MRQ).
2023-08-23 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.